이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

비소세포폐암에 대한 표준 화학요법과 비교하여 표준 면역 요법 Nivolumab에 대한 알약 화학요법, Cabozantinib의 추가 테스트

2026년 11월 11일 업데이트: National Cancer Institute (NCI)

이전에 치료받은 비편평 NSCLC 환자를 대상으로 카보잔티닙 및 카보잔티닙 + 니볼루맙 대 표준 화학 요법의 무작위 2상 시험

This phase II trial compares cabozantinib alone and the combination of cabozantinib and nivolumab to standard chemotherapy in the treatment of patients with non-squamous non-small cell lung cancer (NSCLC). Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Ramucirumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as docetaxel, gemcitabine hydrochloride, paclitaxel, and nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving cabozantinib alone or in combination with nivolumab may be more effective than standard chemotherapy in treating patients with non-small cell lung cancer.

연구 개요

상세 설명

PRIMARY OBJECTIVE:

I. To determine whether cabozantinib alone, or the combination of nivolumab and cabozantinib, as compared to standard chemotherapy alone, extends progression-free survival (PFS) for this patient population with non squamous NSCLC.

SECONDARY OBJECTIVES:

I. To determine the overall survival for each arm of the trial. II. To evaluate the best overall radiographic response rate for each arm of the trial.

III. To evaluate and describe the toxicity profile of monotherapy with cabozantinib, and the combination of nivolumab and cabozantinib in this patient population with non-squamous NSCLC.

EXPLORATORY IMAGING OBJECTIVES:

I. To describe time point tumor response assessment, overall best response, progression-free survival and overall survival using the conventional Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria and the exploratory revised CHOI criteria with all measurements performed by the central review.

II. To compare the progression-free survival using the RECIST1.1 imaging response assessment measurements by site study personnel to those performed by central review.

EXPLORATORY CORRELATIVE OBJECTIVE:

I. To perform correlative biomarker research on tissue and blood biospecimens collected within this trial.

OUTLINE:

STEP 1: Patients are randomized to 1 of 3 arms.

ARM A: Patients receive cabozantinib S-malate orally (PO) once daily (QD). Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit.

ARM B: Patients receive cabozantinib S-malate PO QD and nivolumab intravenously (IV) over 30 minutes on day 1. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit.

ARM C: Patients receive ramucirumab IV over 30-60 minutes and docetaxel IV over 1 hour on day 1, or docetaxel IV over 1 hour on days 1 and 8, or gemcitabine hydrochloride IV on days 1 and 8, or paclitaxel IV over 3 hours on day 1, or nab-paclitaxel IV over 30 minutes on days 1 and 8. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity and at the discretion of the treating physician.

STEP 2: Patients in Arm C experiencing disease progression are assigned to Arm Z.

ARM Z: Patients receive cabozantinib S-malate PO QD and nivolumab IV over 30 minutes on day 1. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit.

Patients in all arms undergo echocardiogram (ECHO) as clinically indicated, computed tomography (CT) throughout the trial, and collection of blood on study.

After the completion of study treatment, patients are followed up every 3 months for up to 3 years.

연구 유형

중재적

등록 (추정된)

117

단계

  • 2 단계

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Alabama
      • Birmingham, Alabama, 미국, 35233
        • Veterans Administration Medical Center - Birmingham
    • Alaska
      • Anchorage, Alaska, 미국, 98508
        • Anchorage Associates in Radiation Medicine
      • Anchorage, Alaska, 미국, 99508
        • Alaska Breast Care and Surgery LLC
      • Anchorage, Alaska, 미국, 99508
        • Alaska Oncology and Hematology LLC
      • Anchorage, Alaska, 미국, 99508
        • Alaska Women's Cancer Care
      • Anchorage, Alaska, 미국, 99508
        • Anchorage Oncology Centre
      • Anchorage, Alaska, 미국, 99508
        • Katmai Oncology Group
      • Anchorage, Alaska, 미국, 99508
        • Providence Alaska Medical Center
      • Anchorage, Alaska, 미국, 99504
        • Anchorage Radiation Therapy Center
      • Fairbanks, Alaska, 미국, 99701
        • Fairbanks Memorial Hospital
    • Arizona
      • Goodyear, Arizona, 미국, 85338
        • CTCA at Western Regional Medical Center
      • Kingman, Arizona, 미국, 86401
        • Kingman Regional Medical Center
      • Phoenix, Arizona, 미국, 85004
        • Cancer Center at Saint Joseph's
      • Tucson, Arizona, 미국, 85719
        • Banner University Medical Center - Tucson
      • Tucson, Arizona, 미국, 85719
        • University of Arizona Cancer Center-North Campus
    • Arkansas
      • Fort Smith, Arkansas, 미국, 72903
        • Mercy Hospital Fort Smith
      • Hot Springs, Arkansas, 미국, 71913
        • CHI Saint Vincent Cancer Center Hot Springs
    • California
      • Arroyo Grande, California, 미국, 93420
        • PCR Oncology
      • Arroyo Grande, California, 미국, 93420
        • Mission Hope Medical Oncology - Arroyo Grande
      • Burbank, California, 미국, 91505
        • Providence Saint Joseph Medical Center/Disney Family Cancer Center
      • Carmichael, California, 미국, 95608
        • Mercy San Juan Medical Center
      • Carmichael, California, 미국, 95608
        • Mercy Cancer Center - Carmichael
      • Elk Grove, California, 미국, 95758
        • Mercy Cancer Center - Elk Grove
      • Fremont, California, 미국, 94538
        • Washington Health
      • Marysville, California, 미국, 95901
        • Fremont - Rideout Cancer Center
      • Orange, California, 미국, 92868
        • Saint Joseph Hospital - Orange
      • Palo Alto, California, 미국, 94304
        • Stanford Cancer Institute Palo Alto
      • Rocklin, California, 미국, 95765
        • Mercy Cancer Center - Rocklin
      • Sacramento, California, 미국, 95817
        • University of California Davis Comprehensive Cancer Center
      • Sacramento, California, 미국, 95816
        • Mercy Cancer Center - Sacramento
      • San Luis Obispo, California, 미국, 93401
        • Pacific Central Coast Health Center-San Luis Obispo
      • Santa Maria, California, 미국, 93444
        • Mission Hope Medical Oncology - Santa Maria
      • Woodland, California, 미국, 95695
        • Woodland Memorial Hospital
    • Colorado
      • Aurora, Colorado, 미국, 80012
        • Rocky Mountain Cancer Centers-Aurora
      • Aurora, Colorado, 미국, 80012
        • The Medical Center of Aurora
      • Boulder, Colorado, 미국, 80303
        • Boulder Community Foothills Hospital
      • Boulder, Colorado, 미국, 80304
        • Rocky Mountain Cancer Centers-Boulder
      • Centennial, Colorado, 미국, 80112
        • Rocky Mountain Cancer Centers - Centennial
      • Colorado Springs, Colorado, 미국, 80907
        • Penrose-Saint Francis Healthcare
      • Colorado Springs, Colorado, 미국, 80907
        • Rocky Mountain Cancer Centers-Penrose
      • Colorado Springs, Colorado, 미국, 80923
        • Saint Francis Cancer Center
      • Denver, Colorado, 미국, 80218
        • Presbyterian - Saint Lukes Medical Center - Health One
      • Denver, Colorado, 미국, 80220
        • Rose Medical Center
      • Denver, Colorado, 미국, 80218
        • Rocky Mountain Cancer Centers-Midtown
      • Denver, Colorado, 미국, 80220
        • Rocky Mountain Cancer Centers-Rose
      • Denver, Colorado, 미국, 80218
        • Colorado Blood Cancer Institute
      • Denver, Colorado, 미국, 80204
        • Cancer Center of Colorado at Sloan's Lake
      • Denver, Colorado, 미국, 80209
        • The Women's Imaging Center
      • Denver, Colorado, 미국, 80206
        • National Jewish Health-Main Campus
      • Denver, Colorado, 미국, 80220
        • Western Surgical Care
      • Denver, Colorado, 미국, 80218
        • Saint Joseph Hospital - Cancer Centers of Colorado
      • Denver, Colorado, 미국, 80210
        • AdventHealth Porter
      • Durango, Colorado, 미국, 81301
        • Mercy Medical Center
      • Durango, Colorado, 미국, 81301
        • CommonSpirit Cancer Center Mercy
      • Englewood, Colorado, 미국, 80113
        • Mountain Blue Cancer Care Center - Swedish
      • Englewood, Colorado, 미국, 80113
        • Swedish Medical Center
      • Englewood, Colorado, 미국, 80113
        • Rocky Mountain Cancer Centers - Swedish
      • Englewood, Colorado, 미국, 80113
        • The Melanoma and Skin Cancer Institute
      • Fort Collins, Colorado, 미국, 80524
        • Poudre Valley Hospital
      • Fort Collins, Colorado, 미국, 80528
        • Cancer Care and Hematology-Fort Collins
      • Golden, Colorado, 미국, 80401
        • National Jewish Health-Western Hematology Oncology
      • Grand Junction, Colorado, 미국, 81501
        • Saint Mary's Hospital and Regional Medical Center
      • Greeley, Colorado, 미국, 80631
        • UCHealth Greeley Hospital
      • Greeley, Colorado, 미국, 80631
        • Banner North Colorado Medical Center
      • Highlands Ranch, Colorado, 미국, 80129
        • UCHealth Highlands Ranch Hospital
      • Lafayette, Colorado, 미국, 80026
        • Good Samaritan Hospital - Cancer Centers of Colorado
      • Lakewood, Colorado, 미국, 80228
        • Rocky Mountain Cancer Centers-Lakewood
      • Lakewood, Colorado, 미국, 80228
        • CommonSpirit Saint Anthony Hospital Cancer Center
      • Littleton, Colorado, 미국, 80120
        • Rocky Mountain Cancer Centers-Littleton
      • Littleton, Colorado, 미국, 80122
        • AdventHealth Littleton
      • Lone Tree, Colorado, 미국, 80124
        • Sky Ridge Medical Center
      • Lone Tree, Colorado, 미국, 80124
        • Rocky Mountain Cancer Centers-Sky Ridge
      • Longmont, Colorado, 미국, 80501
        • Longmont United Hospital
      • Longmont, Colorado, 미국, 80501
        • Rocky Mountain Cancer Centers-Longmont
      • Loveland, Colorado, 미국, 80538
        • Medical Center of the Rockies
      • Loveland, Colorado, 미국, 80539
        • Banner North Colorado Medical Center - Loveland Campus
      • Parker, Colorado, 미국, 80138
        • AdventHealth Parker
      • Pueblo, Colorado, 미국, 81004
        • Saint Mary Corwin Medical Center
      • Thornton, Colorado, 미국, 80260
        • Rocky Mountain Cancer Centers-Thornton
      • Thornton, Colorado, 미국, 80260
        • National Jewish Health-Northern Hematology Oncology
    • Connecticut
      • West Haven, Connecticut, 미국, 06516
        • Veterans Affairs Connecticut Healthcare System-West Haven Campus
    • Florida
      • Aventura, Florida, 미국, 33180
        • Mount Sinai Comprehensive Cancer Center at Aventura
      • Fort Lauderdale, Florida, 미국, 33308
        • Holy Cross Hospital
      • Miami Beach, Florida, 미국, 33140
        • Mount Sinai Medical Center
    • Georgia
      • Atlanta, Georgia, 미국, 30308
        • Emory University Hospital Midtown
      • Atlanta, Georgia, 미국, 30322
        • Emory University Hospital/Winship Cancer Institute
      • Savannah, Georgia, 미국, 31405
        • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
    • Idaho
      • Boise, Idaho, 미국, 83706
        • Saint Alphonsus Cancer Care Center-Boise
      • Boise, Idaho, 미국, 83712
        • Saint Luke's Cancer Institute - Boise
      • Caldwell, Idaho, 미국, 83605
        • Saint Alphonsus Cancer Care Center-Caldwell
      • Coeur d'Alene, Idaho, 미국, 83814
        • Kootenai Health - Coeur d'Alene
      • Emmett, Idaho, 미국, 83617
        • Walter Knox Memorial Hospital
      • Fruitland, Idaho, 미국, 83619
        • Saint Luke's Cancer Institute - Fruitland
      • Meridian, Idaho, 미국, 83642
        • Idaho Urologic Institute-Meridian
      • Meridian, Idaho, 미국, 83642
        • Saint Luke's Cancer Institute - Meridian
      • Nampa, Idaho, 미국, 83687
        • Saint Alphonsus Cancer Care Center-Nampa
      • Nampa, Idaho, 미국, 83687
        • Saint Luke's Cancer Institute - Nampa
      • Post Falls, Idaho, 미국, 83854
        • Kootenai Clinic Cancer Services - Post Falls
      • Sandpoint, Idaho, 미국, 83864
        • Kootenai Clinic Cancer Services - Sandpoint
      • Twin Falls, Idaho, 미국, 83301
        • Saint Luke's Cancer Institute - Twin Falls
    • Illinois
      • Alton, Illinois, 미국, 62002
        • OSF Saint Anthony's Health Center
      • Aurora, Illinois, 미국, 60504
        • Rush-Copley Medical Center
      • Barrington, Illinois, 미국, 60010
        • Advocate Good Shepherd Hospital
      • Bloomington, Illinois, 미국, 61704
        • Illinois CancerCare-Bloomington
      • Canton, Illinois, 미국, 61520
        • Illinois CancerCare-Canton
      • Carbondale, Illinois, 미국, 62902
        • Memorial Hospital of Carbondale
      • Carterville, Illinois, 미국, 62918
        • SIH Cancer Institute
      • Carthage, Illinois, 미국, 62321
        • Illinois CancerCare-Carthage
      • Centralia, Illinois, 미국, 62801
        • Centralia Oncology Clinic
      • Centralia, Illinois, 미국, 62801
        • Saint Mary's Hospital
      • Chicago, Illinois, 미국, 60612
        • University of Illinois
      • Chicago, Illinois, 미국, 60657
        • Advocate Illinois Masonic Medical Center
      • Crystal Lake, Illinois, 미국, 60014
        • AMG Crystal Lake - Oncology
      • Danville, Illinois, 미국, 61832
        • Carle at The Riverfront
      • Decatur, Illinois, 미국, 62526
        • Decatur Memorial Hospital
      • Decatur, Illinois, 미국, 62526
        • Cancer Care Specialists of Illinois - Decatur
      • Dixon, Illinois, 미국, 61021
        • Illinois CancerCare-Dixon
      • Downers Grove, Illinois, 미국, 60515
        • Advocate Good Samaritan Hospital
      • Effingham, Illinois, 미국, 62401
        • Crossroads Cancer Center
      • Effingham, Illinois, 미국, 62401
        • Carle Physician Group-Effingham
      • Elgin, Illinois, 미국, 60123
        • Advocate Sherman Hospital
      • Eureka, Illinois, 미국, 61530
        • Illinois CancerCare-Eureka
      • Galesburg, Illinois, 미국, 61401
        • Western Illinois Cancer Treatment Center
      • Galesburg, Illinois, 미국, 61401
        • Illinois CancerCare-Galesburg
      • Hazel Crest, Illinois, 미국, 60429
        • Advocate South Suburban Hospital
      • Hines, Illinois, 미국, 60141
        • Edward Hines Jr VA Hospital
      • Kewanee, Illinois, 미국, 61443
        • Illinois CancerCare-Kewanee Clinic
      • Libertyville, Illinois, 미국, 60048
        • Condell Memorial Hospital
      • Libertyville, Illinois, 미국, 60048
        • AMG Libertyville - Oncology
      • Macomb, Illinois, 미국, 61455
        • Illinois CancerCare-Macomb
      • Mattoon, Illinois, 미국, 61938
        • Carle Physician Group-Mattoon/Charleston
      • Mount Vernon, Illinois, 미국, 62864
        • SSM Health Good Samaritan
      • O'Fallon, Illinois, 미국, 62269
        • Cancer Care Center of O'Fallon
      • Oak Lawn, Illinois, 미국, 60453-2699
        • Advocate Christ Medical Center
      • Ottawa, Illinois, 미국, 61350
        • Illinois CancerCare-Ottawa Clinic
      • Park Ridge, Illinois, 미국, 60068
        • Advocate Lutheran General Hospital
      • Pekin, Illinois, 미국, 61554
        • Illinois CancerCare-Pekin
      • Peoria, Illinois, 미국, 61636
        • Methodist Medical Center of Illinois
      • Peoria, Illinois, 미국, 61615
        • Illinois CancerCare-Peoria
      • Peru, Illinois, 미국, 61354
        • Illinois CancerCare-Peru
      • Peru, Illinois, 미국, 61354
        • Valley Radiation Oncology
      • Princeton, Illinois, 미국, 61356
        • Illinois CancerCare-Princeton
      • Rockford, Illinois, 미국, 61114
        • UW Health Carbone Cancer Center Rockford
      • Springfield, Illinois, 미국, 62702
        • Southern Illinois University School of Medicine
      • Springfield, Illinois, 미국, 62702
        • Springfield Clinic
      • Springfield, Illinois, 미국, 62781
        • Springfield Memorial Hospital
      • Swansea, Illinois, 미국, 62226
        • Southwest Illinois Health Services LLP
      • Urbana, Illinois, 미국, 61801
        • Carle Cancer Center
      • Urbana, Illinois, 미국, 61801
        • The Carle Foundation Hospital
      • Washington, Illinois, 미국, 61571
        • Illinois CancerCare - Washington
      • Yorkville, Illinois, 미국, 60560
        • Rush-Copley Healthcare Center
    • Indiana
      • Richmond, Indiana, 미국, 47374
        • Reid Health
      • South Bend, Indiana, 미국, 46601
        • Memorial Hospital of South Bend
    • Iowa
      • Ames, Iowa, 미국, 50010
        • Mary Greeley Medical Center
      • Ames, Iowa, 미국, 50010
        • McFarland Clinic - Ames
      • Bettendorf, Iowa, 미국, 52722
        • University of Iowa Healthcare Cancer Services Quad Cities
      • Boone, Iowa, 미국, 50036
        • McFarland Clinic - Boone
      • Carroll, Iowa, 미국, 51401
        • Saint Anthony Regional Hospital
      • Clive, Iowa, 미국, 50325
        • Mercy Cancer Center-West Lakes
      • Clive, Iowa, 미국, 50325
        • UI Health Care Mission Cancer and Blood - West Des Moines Clinic
      • Council Bluffs, Iowa, 미국, 51503
        • Alegent Health Mercy Hospital
      • Council Bluffs, Iowa, 미국, 51503
        • Heartland Oncology and Hematology LLP
      • Council Bluffs, Iowa, 미국, 51503
        • Methodist Jennie Edmundson Hospital
      • Creston, Iowa, 미국, 50801
        • Greater Regional Medical Center
      • Des Moines, Iowa, 미국, 50309
        • Iowa Methodist Medical Center
      • Des Moines, Iowa, 미국, 50314
        • Mercy Medical Center - Des Moines
      • Des Moines, Iowa, 미국, 50314
        • Broadlawns Medical Center
      • Des Moines, Iowa, 미국, 50316
        • Iowa Lutheran Hospital
      • Des Moines, Iowa, 미국, 50309
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
      • Des Moines, Iowa, 미국, 50314
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
      • Fort Dodge, Iowa, 미국, 50501
        • McFarland Clinic - Trinity Cancer Center
      • Fort Dodge, Iowa, 미국, 50501
        • UI Healthcare Mission Cancer and Blood - Fort Dodge
      • Iowa City, Iowa, 미국, 52242
        • University of Iowa/Holden Comprehensive Cancer Center
      • Jefferson, Iowa, 미국, 50129
        • McFarland Clinic - Jefferson
      • Marshalltown, Iowa, 미국, 50158
        • McFarland Clinic - Marshalltown
      • West Des Moines, Iowa, 미국, 50266-7700
        • Methodist West Hospital
      • West Des Moines, Iowa, 미국, 50266
        • Mercy Medical Center-West Lakes
    • Kansas
      • Garden City, Kansas, 미국, 67846
        • Central Care Cancer Center - Garden City
      • Great Bend, Kansas, 미국, 67530
        • Central Care Cancer Center - Great Bend
      • Hays, Kansas, 미국, 67601
        • HaysMed
      • Lawrence, Kansas, 미국, 66044
        • Lawrence Memorial Hospital
      • Olathe, Kansas, 미국, 66061
        • The University of Kansas Cancer Center - Olathe
      • Overland Park, Kansas, 미국, 66213
        • Saint Luke's South Hospital
      • Pittsburg, Kansas, 미국, 66762
        • Freeman Physician Group of Pittsburg
      • Pittsburg, Kansas, 미국, 66762
        • Mercy Hospital Pittsburg
      • Salina, Kansas, 미국, 67401
        • Salina Regional Health Center
      • Topeka, Kansas, 미국, 66606
        • University of Kansas Health System Saint Francis Campus
    • Kentucky
      • Bardstown, Kentucky, 미국, 40004
        • CommonSpirit Saint Joseph Hospital - Bardstown
      • Corbin, Kentucky, 미국, 40701
        • Commonwealth Cancer Center-Corbin
      • Lexington, Kentucky, 미국, 40504
        • Saint Joseph Radiation Oncology Resource Center
      • Lexington, Kentucky, 미국, 40509
        • CommonSpirit Saint Joseph Medical Center - East Lexington
      • Lexington, Kentucky, 미국, 40504
        • CommonSpirit Saint Joseph Hospital - Lexington
      • London, Kentucky, 미국, 40741
        • CommonSpirit Saint Joseph Hospital London
      • Louisville, Kentucky, 미국, 40202
        • Jewish Hospital
      • Louisville, Kentucky, 미국, 40245
        • UofL Health Medical Center Northeast
      • Louisville, Kentucky, 미국, 40215
        • Saints Mary and Elizabeth Hospital
      • Mount Sterling, Kentucky, 미국, 40353
        • CommonSpirit Saint Joseph Hospital Mount Sterling
      • Owensboro, Kentucky, 미국, 42303
        • Owensboro Health Mitchell Memorial Cancer Center
      • Paducah, Kentucky, 미국, 42003
        • Mercy Health - Paducah Cancer Center
      • Shepherdsville, Kentucky, 미국, 40165
        • Jewish Hospital Medical Center South
    • Louisiana
      • Baton Rouge, Louisiana, 미국, 70805
        • LSU Health Baton Rouge-North Clinic
      • Baton Rouge, Louisiana, 미국, 70809
        • Louisiana Hematology Oncology Associates LLC
      • Baton Rouge, Louisiana, 미국, 70809
        • Mary Bird Perkins Cancer Center
      • Baton Rouge, Louisiana, 미국, 70808
        • Our Lady of The Lake
      • Baton Rouge, Louisiana, 미국, 70808
        • Our Lady of the Lake Physician Group
      • Covington, Louisiana, 미국, 70433
        • Northshore Oncology Associates-Covington
      • Houma, Louisiana, 미국, 70360
        • Terrebonne General Medical Center
    • Maine
      • Augusta, Maine, 미국, 04330
        • Harold Alfond Center for Cancer Care
      • Biddeford, Maine, 미국, 04005
        • MaineHealth Maine Medical Center - Biddeford
      • Sanford, Maine, 미국, 04073
        • MaineHealth Cancer Care and IV Therapy - Sanford
      • South Portland, Maine, 미국, 04106
        • MaineHealth Cancer Care and IV Therapy - South Portland
    • Maryland
      • Baltimore, Maryland, 미국, 21229
        • Saint Agnes Hospital
    • Massachusetts
      • Boston, Massachusetts, 미국, 02118
        • Boston Medical Center
      • Worcester, Massachusetts, 미국, 01655
        • UMass Memorial Medical Center - University Campus
    • Michigan
      • Adrian, Michigan, 미국, 49221
        • Hickman Cancer Center
      • Ann Arbor, Michigan, 미국, 48106
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
      • Battle Creek, Michigan, 미국, 49017
        • Bronson Battle Creek
      • Brighton, Michigan, 미국, 48114
        • Trinity Health IHA Medical Group Hematology Oncology - Brighton
      • Brighton, Michigan, 미국, 48114
        • Trinity Health Medical Center - Brighton
      • Canton, Michigan, 미국, 48188
        • Trinity Health IHA Medical Group Hematology Oncology - Canton
      • Canton, Michigan, 미국, 48188
        • Trinity Health Medical Center - Canton
      • Caro, Michigan, 미국, 48723
        • Caro Cancer Center
      • Chelsea, Michigan, 미국, 48118
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
      • Chelsea, Michigan, 미국, 48118
        • Chelsea Hospital
      • Clarkston, Michigan, 미국, 48346
        • Hematology Oncology Consultants-Clarkston
      • Clarkston, Michigan, 미국, 48346
        • Newland Medical Associates-Clarkston
      • Detroit, Michigan, 미국, 48236
        • Henry Ford Health Saint John Hospital
      • East China Township, Michigan, 미국, 48054
        • Henry Ford River District Hospital
      • Flint, Michigan, 미국, 48503
        • Hurley Medical Center
      • Flint, Michigan, 미국, 48503
        • Genesee Hematology Oncology PC
      • Flint, Michigan, 미국, 48503
        • Genesys Hurley Cancer Institute
      • Flint, Michigan, 미국, 48503
        • Cancer Hematology Centers - Flint
      • Grand Rapids, Michigan, 미국, 49503
        • Trinity Health Grand Rapids Hospital
      • Grand Rapids, Michigan, 미국, 49503
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
      • Grand Rapids, Michigan, 미국, 49503
        • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
      • Grosse Pointe Woods, Michigan, 미국, 48236
        • Henry Ford Saint John Hospital - Academic
      • Grosse Pointe Woods, Michigan, 미국, 48236
        • Henry Ford Saint John Hospital - Breast
      • Grosse Pointe Woods, Michigan, 미국, 48236
        • Henry Ford Saint John Hospital - Van Elslander
      • Kalamazoo, Michigan, 미국, 49007
        • West Michigan Cancer Center
      • Kalamazoo, Michigan, 미국, 49007
        • Bronson Methodist Hospital
      • Kalamazoo, Michigan, 미국, 49009
        • Beacon Kalamazoo Cancer Center
      • Kalamazoo, Michigan, 미국, 49048
        • Beacon Kalamazoo
      • Lansing, Michigan, 미국, 48912
        • University of Michigan Health - Sparrow Lansing
      • Livonia, Michigan, 미국, 48154
        • Trinity Health Saint Mary Mercy Livonia Hospital
      • Livonia, Michigan, 미국, 48154
        • Hope Cancer Clinic
      • Macomb, Michigan, 미국, 48044
        • Henry Ford Warren Hospital - Breast Macomb
      • Macomb, Michigan, 미국, 48044
        • Henry Ford Saint John Hospital - Macomb Medical
      • Marlette, Michigan, 미국, 48453
        • Saint Mary's Oncology/Hematology Associates of Marlette
      • Monroe, Michigan, 미국, 48162
        • Toledo Clinic Cancer Centers-Monroe
      • Muskegon, Michigan, 미국, 49444
        • Trinity Health Muskegon Hospital
      • Niles, Michigan, 미국, 49120
        • Corewell Health Lakeland Hospitals - Niles Hospital
      • Norton Shores, Michigan, 미국, 49444
        • Cancer and Hematology Centers of Western Michigan - Norton Shores
      • Novi, Michigan, 미국, 48374
        • Henry Ford Health Providence Novi Hospital
      • Pontiac, Michigan, 미국, 48341
        • Hope Cancer Center
      • Pontiac, Michigan, 미국, 48341
        • Trinity Health Saint Joseph Mercy Oakland Hospital
      • Pontiac, Michigan, 미국, 48341
        • Michigan Healthcare Professionals Pontiac
      • Pontiac, Michigan, 미국, 48341
        • Trinity Health IHA Medical Group-Alice Gustafson Center
      • Reed City, Michigan, 미국, 49677
        • Corewell Health Reed City Hospital
      • Rochester Hills, Michigan, 미국, 48309
        • Henry Ford Rochester Hospital
      • Saginaw, Michigan, 미국, 48604
        • Oncology Hematology Associates of Saginaw Valley PC
      • Saginaw, Michigan, 미국, 48601
        • MyMichigan Medical Center Saginaw
      • Saint Joseph, Michigan, 미국, 49085
        • Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
      • Saint Joseph, Michigan, 미국, 49085
        • Corewell Health Lakeland Hospitals - Saint Joseph Hospital
      • Southfield, Michigan, 미국, 48075
        • Henry Ford Health Providence Southfield Hospital
      • Sterling Heights, Michigan, 미국, 48312
        • Bhadresh Nayak MD PC-Sterling Heights
      • Tawas City, Michigan, 미국, 48764
        • MyMichigan Medical Center Tawas
      • Traverse City, Michigan, 미국, 49684
        • Munson Medical Center
      • Warren, Michigan, 미국, 48088
        • Advanced Breast Care Center PLLC
      • Warren, Michigan, 미국, 48093
        • Macomb Hematology Oncology PC
      • Warren, Michigan, 미국, 48093
        • Henry Ford Madison Heights Hospital - Breast
      • Warren, Michigan, 미국, 48093
        • Henry Ford Health Warren Hospital
      • Warren, Michigan, 미국, 48093
        • Henry Ford Warren Hospital - GLCMS
      • West Branch, Michigan, 미국, 48661
        • Saint Mary's Oncology/Hematology Associates of West Branch
      • Wyoming, Michigan, 미국, 49519
        • University of Michigan Health - West
      • Ypsilanti, Michigan, 미국, 48197
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
      • Ypsilanti, Michigan, 미국, 48106
        • Huron Gastroenterology PC
    • Minnesota
      • Aitkin, Minnesota, 미국, 56431
        • Riverwood Healthcare Center
      • Baxter, Minnesota, 미국, 56425
        • Essentia Health - Baxter Clinic
      • Brainerd, Minnesota, 미국, 56401
        • Essentia Health Saint Joseph's Medical Center
      • Burnsville, Minnesota, 미국, 55337
        • Fairview Ridges Hospital
      • Burnsville, Minnesota, 미국, 55337
        • Minnesota Oncology - Burnsville
      • Cambridge, Minnesota, 미국, 55008
        • Cambridge Medical Center
      • Coon Rapids, Minnesota, 미국, 55433
        • Mercy Hospital
      • Deer River, Minnesota, 미국, 56636
        • Essentia Health - Deer River Clinic
      • Detroit Lakes, Minnesota, 미국, 56501
        • Essentia Health Saint Mary's - Detroit Lakes Clinic
      • Duluth, Minnesota, 미국, 55805
        • Essentia Health Cancer Center
      • Duluth, Minnesota, 미국, 55805
        • Essentia Health Saint Mary's Medical Center
      • Duluth, Minnesota, 미국, 55805
        • Miller-Dwan Hospital
      • Edina, Minnesota, 미국, 55435
        • Fairview Southdale Hospital
      • Ely, Minnesota, 미국, 55731
        • Essentia Health - Ely Clinic
      • Fergus Falls, Minnesota, 미국, 56537
        • Lake Region Healthcare Corporation-Cancer Care
      • Fosston, Minnesota, 미국, 56542
        • Essentia Health - Fosston
      • Fridley, Minnesota, 미국, 55432
        • Unity Hospital
      • Hibbing, Minnesota, 미국, 55746
        • Essentia Health Hibbing Clinic
      • International Falls, Minnesota, 미국, 56649
        • Essentia Health - International Falls Clinic
      • Maple Grove, Minnesota, 미국, 55369
        • Fairview Clinics and Surgery Center Maple Grove
      • Maplewood, Minnesota, 미국, 55109
        • Saint John's Hospital - Healtheast
      • Maplewood, Minnesota, 미국, 55109
        • Minnesota Oncology Hematology PA-Maplewood
      • Minneapolis, Minnesota, 미국, 55415
        • Hennepin County Medical Center
      • Minneapolis, Minnesota, 미국, 55407
        • Abbott-Northwestern Hospital
      • Minneapolis, Minnesota, 미국, 55454
        • Health Partners Inc
      • Monticello, Minnesota, 미국, 55362
        • Monticello Cancer Center
      • Moose Lake, Minnesota, 미국, 55767
        • Essentia Health - Moose Lake Clinic
      • New Ulm, Minnesota, 미국, 56073
        • New Ulm Medical Center
      • Park Rapids, Minnesota, 미국, 56470
        • Essentia Health - Park Rapids
      • Princeton, Minnesota, 미국, 55371
        • Fairview Northland Medical Center
      • Robbinsdale, Minnesota, 미국, 55422
        • North Memorial Medical Health Center
      • Saint Louis Park, Minnesota, 미국, 55416
        • Park Nicollet Clinic - Saint Louis Park
      • Saint Paul, Minnesota, 미국, 55101
        • Regions Hospital
      • Saint Paul, Minnesota, 미국, 55102
        • United Hospital
      • Sandstone, Minnesota, 미국, 55072
        • Essentia Health Sandstone
      • Shakopee, Minnesota, 미국, 55379
        • Saint Francis Regional Medical Center
      • Stillwater, Minnesota, 미국, 55082
        • Lakeview Hospital
      • Virginia, Minnesota, 미국, 55792
        • Essentia Health Virginia Clinic
      • Waconia, Minnesota, 미국, 55387
        • Ridgeview Medical Center
      • Willmar, Minnesota, 미국, 56201
        • Rice Memorial Hospital
      • Woodbury, Minnesota, 미국, 55125
        • Minnesota Oncology Hematology PA-Woodbury
      • Wyoming, Minnesota, 미국, 55092
        • Fairview Lakes Medical Center
    • Missouri
      • Ballwin, Missouri, 미국, 63011
        • Mercy Oncology and Hematology - Clayton-Clarkson
      • Bolivar, Missouri, 미국, 65613
        • Central Care Cancer Center - Bolivar
      • Branson, Missouri, 미국, 65616
        • Cox Cancer Center Branson
      • Cape Girardeau, Missouri, 미국, 63703
        • Saint Francis Medical Center
      • Cape Girardeau, Missouri, 미국, 63703
        • Mercy Cancer Center - Cape Girardeau
      • City of Saint Peters, Missouri, 미국, 63376
        • Siteman Cancer Center at Saint Peters Hospital
      • Columbia, Missouri, 미국, 65212
        • MU Health - University Hospital/Ellis Fischel Cancer Center
      • Creve Coeur, Missouri, 미국, 63141
        • Siteman Cancer Center at West County Hospital
      • Farmington, Missouri, 미국, 63640
        • Parkland Health Center - Farmington
      • Jefferson City, Missouri, 미국, 65109
        • MU Health Care Goldschmidt Cancer Center
      • Joplin, Missouri, 미국, 64804
        • Freeman Health System
      • Joplin, Missouri, 미국, 64804
        • Mercy Hospital Joplin
      • Kansas City, Missouri, 미국, 64111
        • Saint Luke's Hospital of Kansas City
      • Kansas City, Missouri, 미국, 64108
        • University Health Truman Medical Center
      • Lee's Summit, Missouri, 미국, 64086
        • Saint Luke's East - Lee's Summit
      • Rolla, Missouri, 미국, 65401
        • Mercy Clinic-Rolla-Cancer and Hematology
      • Rolla, Missouri, 미국, 65401
        • Phelps Health Delbert Day Cancer Institute
      • Saint Joseph, Missouri, 미국, 64506
        • Heartland Regional Medical Center
      • Sainte Genevieve, Missouri, 미국, 63670
        • Sainte Genevieve County Memorial Hospital
      • Springfield, Missouri, 미국, 65807
        • CoxHealth South Hospital
      • Springfield, Missouri, 미국, 65804
        • Mercy Hospital Springfield
      • St Louis, Missouri, 미국, 63110
        • Washington University School of Medicine
      • St Louis, Missouri, 미국, 63129
        • Siteman Cancer Center-South County
      • St Louis, Missouri, 미국, 63136
        • Siteman Cancer Center at Christian Hospital
      • St Louis, Missouri, 미국, 63131
        • Missouri Baptist Medical Center
      • St Louis, Missouri, 미국, 63109
        • Mercy Infusion Center - Chippewa
      • St Louis, Missouri, 미국, 63141
        • Mercy Hospital Saint Louis
      • St Louis, Missouri, 미국, 63128
        • Mercy Hospital South
      • Sullivan, Missouri, 미국, 63080
        • Missouri Baptist Sullivan Hospital
      • Washington, Missouri, 미국, 63090
        • Mercy Hospital Washington
    • Montana
      • Anaconda, Montana, 미국, 59711
        • Community Hospital of Anaconda
      • Billings, Montana, 미국, 59101
        • Billings Clinic Cancer Center
      • Billings, Montana, 미국, 59101
        • Saint Vincent Healthcare
      • Billings, Montana, 미국, 59102
        • Saint Vincent Frontier Cancer Center
      • Bozeman, Montana, 미국, 59715
        • Bozeman Health Deaconess Hospital
      • Great Falls, Montana, 미국, 59405
        • Great Falls Clinic
      • Great Falls, Montana, 미국, 59405
        • Benefis Sletten Cancer Institute
      • Kalispell, Montana, 미국, 59901
        • Logan Health Medical Center
      • Missoula, Montana, 미국, 59802
        • Saint Patrick Hospital - Community Hospital
      • Missoula, Montana, 미국, 59804
        • Community Medical Center
    • Nebraska
      • Bellevue, Nebraska, 미국, 68123
        • Nebraska Medicine-Bellevue
      • Grand Island, Nebraska, 미국, 68803
        • Nebraska Cancer Specialists/Oncology Hematology West PC
      • Kearney, Nebraska, 미국, 68847
        • CHI Health Good Samaritan
      • Lincoln, Nebraska, 미국, 68510
        • Saint Elizabeth Regional Medical Center
      • Omaha, Nebraska, 미국, 68114
        • Nebraska Methodist Hospital
      • Omaha, Nebraska, 미국, 68198
        • University of Nebraska Medical Center
      • Omaha, Nebraska, 미국, 68124
        • Alegent Health Bergan Mercy Medical Center
      • Omaha, Nebraska, 미국, 68118
        • Nebraska Medicine-Village Pointe
      • Omaha, Nebraska, 미국, 68122
        • Alegent Health Immanuel Medical Center
      • Omaha, Nebraska, 미국, 68130
        • Alegent Health Lakeside Hospital
      • Omaha, Nebraska, 미국, 68114
        • Oncology Associates PC
      • Omaha, Nebraska, 미국, 68114
        • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC
      • Papillion, Nebraska, 미국, 68046
        • Midlands Community Hospital
    • Nevada
      • Carson City, Nevada, 미국, 89703
        • Carson Tahoe Regional Medical Center
      • Henderson, Nevada, 미국, 89052
        • Comprehensive Cancer Centers of Nevada - Henderson
      • Henderson, Nevada, 미국, 89052
        • Cancer and Blood Specialists-Henderson
      • Henderson, Nevada, 미국, 89052
        • Las Vegas Cancer Center-Henderson
      • Henderson, Nevada, 미국, 89074
        • Comprehensive Cancer Centers of Nevada-Southeast Henderson
      • Henderson, Nevada, 미국, 89052
        • Comprehensive Cancer Centers of Nevada-Horizon Ridge
      • Henderson, Nevada, 미국, 89074
        • Las Vegas Urology - Green Valley
      • Henderson, Nevada, 미국, 89074
        • Las Vegas Urology - Pebble
      • Henderson, Nevada, 미국, 89074
        • Urology Specialists of Nevada - Green Valley
      • Henderson, Nevada, 미국, 89074
        • Oncology Las Vegas - Henderson
      • Las Vegas, Nevada, 미국, 89144
        • Summerlin Hospital Medical Center
      • Las Vegas, Nevada, 미국, 89109
        • Sunrise Hospital and Medical Center
      • Las Vegas, Nevada, 미국, 89102
        • OptumCare Cancer Care at Charleston
      • Las Vegas, Nevada, 미국, 89106
        • Radiation Oncology Centers of Nevada Central
      • Las Vegas, Nevada, 미국, 89119
        • Radiation Oncology Centers of Nevada Southeast
      • Las Vegas, Nevada, 미국, 89128
        • Comprehensive Cancer Centers of Nevada - Northwest
      • Las Vegas, Nevada, 미국, 89128
        • OptumCare Cancer Care at MountainView
      • Las Vegas, Nevada, 미국, 89135
        • Alliance for Childhood Diseases/Cure 4 the Kids Foundation
      • Las Vegas, Nevada, 미국, 89144
        • Comprehensive Cancer Centers of Nevada - Town Center
      • Las Vegas, Nevada, 미국, 89144
        • Comprehensive Cancer Centers of Nevada-Summerlin
      • Las Vegas, Nevada, 미국, 89148
        • Comprehensive Cancer Centers of Nevada
      • Las Vegas, Nevada, 미국, 89169
        • Comprehensive Cancer Centers of Nevada - Central Valley
      • Las Vegas, Nevada, 미국, 89102
        • University Medical Center of Southern Nevada
      • Las Vegas, Nevada, 미국, 89106
        • Cancer and Blood Specialists-Shadow
      • Las Vegas, Nevada, 미국, 89109
        • HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway
      • Las Vegas, Nevada, 미국, 89113
        • HealthCare Partners Medical Group Oncology/Hematology-San Martin
      • Las Vegas, Nevada, 미국, 89128
        • Cancer and Blood Specialists-Tenaya
      • Las Vegas, Nevada, 미국, 89128
        • HealthCare Partners Medical Group Oncology/Hematology-Tenaya
      • Las Vegas, Nevada, 미국, 89148-2405
        • Las Vegas Cancer Center-Medical Center
      • Las Vegas, Nevada, 미국, 89149
        • HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills
      • Las Vegas, Nevada, 미국, 89128
        • Ann M Wierman MD LTD
      • Las Vegas, Nevada, 미국, 89074
        • Las Vegas Urology - Pecos
      • Las Vegas, Nevada, 미국, 89102
        • Desert West Surgery
      • Las Vegas, Nevada, 미국, 89103
        • Hope Cancer Care of Nevada
      • Las Vegas, Nevada, 미국, 89106
        • Urology Specialists of Nevada - Central
      • Las Vegas, Nevada, 미국, 89113
        • Las Vegas Prostate Cancer Center
      • Las Vegas, Nevada, 미국, 89113
        • Las Vegas Urology - Sunset
      • Las Vegas, Nevada, 미국, 89128
        • Las Vegas Urology - Cathedral Rock
      • Las Vegas, Nevada, 미국, 89128
        • Las Vegas Urology - Smoke Ranch
      • Las Vegas, Nevada, 미국, 89128
        • Urology Specialists of Nevada - Northwest
      • Las Vegas, Nevada, 미국, 89169
        • University Cancer Center
      • Las Vegas, Nevada, 미국, 89113
        • Urology Specialists of Nevada - Southwest
      • Las Vegas, Nevada, 미국, 89128
        • Oncology Las Vegas - Tenaya
      • Las Vegas, Nevada, 미국, 89183
        • OptumCare Cancer Care at Fort Apache
      • Pahrump, Nevada, 미국, 89048
        • Hope Cancer Care of Nevada-Pahrump
      • Reno, Nevada, 미국, 89502
        • Renown Regional Medical Center
      • Reno, Nevada, 미국, 89503
        • Saint Mary's Regional Medical Center
      • Reno, Nevada, 미국, 89509
        • Radiation Oncology Associates
    • New Hampshire
      • Concord, New Hampshire, 미국, 03301
        • New Hampshire Oncology Hematology PA-Concord
      • Manchester, New Hampshire, 미국, 03103
        • Solinsky Center for Cancer Care
      • Manchester, New Hampshire, 미국, 03103
        • Elliot Hospital
    • New Jersey
      • Moorestown, New Jersey, 미국, 08057
        • Virtua Samson Cancer Center
      • Mount Holly, New Jersey, 미국, 08060
        • Virtua Memorial
      • Voorhees Township, New Jersey, 미국, 08043
        • Virtua Voorhees
    • New Mexico
      • Albuquerque, New Mexico, 미국, 87106
        • University of New Mexico Cancer Center
    • New York
      • Glens Falls, New York, 미국, 12801
        • Glens Falls Hospital
      • The Bronx, New York, 미국, 10461
        • Montefiore Medical Center-Einstein Campus
      • The Bronx, New York, 미국, 10467
        • Montefiore Medical Center - Moses Campus
      • The Bronx, New York, 미국, 10461
        • Montefiore Medical Center-Weiler Hospital
    • North Carolina
      • Kenansville, North Carolina, 미국, 28349
        • ECU Health Oncology Kenansville
      • Kinston, North Carolina, 미국, 28501
        • ECU Health Oncology Kinston
      • Pinehurst, North Carolina, 미국, 28374
        • FirstHealth of the Carolinas-Moore Regional Hospital
      • Richlands, North Carolina, 미국, 28574
        • ECU Health Oncology Richlands
      • Washington, North Carolina, 미국, 27889
        • Marion L Shepard Cancer Center - ECU Health Beaufort Hospital
    • North Dakota
      • Fargo, North Dakota, 미국, 58103
        • Essentia Health Cancer Center-South University Clinic
      • Jamestown, North Dakota, 미국, 58401
        • Essentia Health - Jamestown Clinic
    • Ohio
      • Alliance, Ohio, 미국, 44601
        • Aultman Alliance Community Hospital
      • Beavercreek, Ohio, 미국, 45431
        • Indu and Raj Soin Medical Center
      • Boardman, Ohio, 미국, 44512
        • Saint Elizabeth Boardman Hospital
      • Canton, Ohio, 미국, 44708
        • Cleveland Clinic Mercy Hospital
      • Canton, Ohio, 미국, 44710
        • Aultman Health Foundation
      • Centerville, Ohio, 미국, 45459
        • Miami Valley Hospital South
      • Centerville, Ohio, 미국, 45459
        • Dayton Physicians LLC-Miami Valley South
      • Cincinnati, Ohio, 미국, 45220
        • Good Samaritan Hospital - Cincinnati
      • Cincinnati, Ohio, 미국, 45242
        • Bethesda North Hospital
      • Cincinnati, Ohio, 미국, 45236
        • Oncology Hematology Care Inc-Kenwood
      • Cincinnati, Ohio, 미국, 45247
        • TriHealth Cancer Institute-Westside
      • Cincinnati, Ohio, 미국, 45255
        • TriHealth Cancer Institute-Anderson
      • Cleveland, Ohio, 미국, 44195
        • Cleveland Clinic Foundation
      • Cleveland, Ohio, 미국, 44111
        • Cleveland Clinic Cancer Center/Fairview Hospital
      • Dayton, Ohio, 미국, 45409
        • Miami Valley Hospital
      • Dayton, Ohio, 미국, 45415
        • Miami Valley Hospital North
      • Dayton, Ohio, 미국, 45415
        • Dayton Physician LLC - Englewood
      • Dayton, Ohio, 미국, 45409
        • Premier Blood and Cancer Center
      • Findlay, Ohio, 미국, 45840
        • Blanchard Valley Hospital
      • Findlay, Ohio, 미국, 45840
        • Armes Family Cancer Center
      • Findlay, Ohio, 미국, 45840
        • Orion Cancer Care
      • Franklin, Ohio, 미국, 45005-1066
        • Atrium Medical Center-Middletown Regional Hospital
      • Franklin, Ohio, 미국, 45005
        • Dayton Physicians LLC-Atrium
      • Greenville, Ohio, 미국, 45331
        • Wayne Hospital
      • Greenville, Ohio, 미국, 45331
        • Dayton Physicians LLC-Wayne
      • Greenville, Ohio, 미국, 45331
        • Miami Valley Cancer Care and Infusion
      • Kettering, Ohio, 미국, 45429
        • Kettering Medical Center
      • Kettering, Ohio, 미국, 45409
        • Greater Dayton Cancer Center
      • Kettering, Ohio, 미국, 45420
        • First Dayton Cancer Care
      • Mansfield, Ohio, 미국, 44906
        • Cleveland Clinic Cancer Center Mansfield
      • Maumee, Ohio, 미국, 43537
        • Toledo Clinic Cancer Centers-Maumee
      • Mayfield Heights, Ohio, 미국, 44124
        • Hillcrest Hospital Cancer Center
      • Perrysburg, Ohio, 미국, 43551
        • Mercy Health - Perrysburg Hospital
      • Sandusky, Ohio, 미국, 44870
        • North Coast Cancer Care
      • Springfield, Ohio, 미국, 45504
        • Springfield Regional Cancer Center
      • Springfield, Ohio, 미국, 45504
        • Springfield Regional Medical Center
      • Strongsville, Ohio, 미국, 44136
        • Cleveland Clinic Cancer Center Strongsville
      • Toledo, Ohio, 미국, 43623
        • Mercy Health - Saint Anne Hospital
      • Toledo, Ohio, 미국, 43623
        • Toledo Clinic Cancer Centers-Toledo
      • Troy, Ohio, 미국, 45373
        • Upper Valley Medical Center
      • Troy, Ohio, 미국, 45373
        • Dayton Physicians LLC - Troy
      • Warren, Ohio, 미국, 44484
        • Saint Joseph Warren Hospital
      • Warrensville Heights, Ohio, 미국, 44122
        • South Pointe Hospital
      • Wooster, Ohio, 미국, 44691
        • Cleveland Clinic Wooster Family Health and Surgery Center
      • Wright-Patterson Air Force Base, Ohio, 미국, 45433
        • Wright-Patterson Medical Center
      • Youngstown, Ohio, 미국, 44501
        • Saint Elizabeth Youngstown Hospital
    • Oklahoma
      • Oklahoma City, Oklahoma, 미국, 73120
        • Mercy Hospital Oklahoma City
    • Oregon
      • Baker City, Oregon, 미국, 97814
        • Saint Alphonsus Cancer Care Center-Baker City
      • Bend, Oregon, 미국, 97701
        • Saint Charles Health System
      • Clackamas, Oregon, 미국, 97015
        • Clackamas Radiation Oncology Center
      • Clackamas, Oregon, 미국, 97015
        • Providence Cancer Institute Clackamas Clinic
      • Coos Bay, Oregon, 미국, 97420
        • Bay Area Hospital
      • Newberg, Oregon, 미국, 97132
        • Providence Newberg Medical Center
      • Ontario, Oregon, 미국, 97914
        • Saint Alphonsus Cancer Care Center-Ontario
      • Oregon City, Oregon, 미국, 97045
        • Providence Willamette Falls Medical Center
      • Portland, Oregon, 미국, 97239
        • Oregon Health and Science University
      • Portland, Oregon, 미국, 97213
        • Providence Portland Medical Center
      • Portland, Oregon, 미국, 97225
        • Providence Saint Vincent Medical Center
      • Redmond, Oregon, 미국, 97756
        • Saint Charles Health System-Redmond
    • Pennsylvania
      • Allentown, Pennsylvania, 미국, 18103
        • Lehigh Valley Hospital-Cedar Crest
      • Allentown, Pennsylvania, 미국, 18104
        • Saint Luke's Cancer Center - Allentown
      • Bethlehem, Pennsylvania, 미국, 18017
        • Lehigh Valley Hospital - Muhlenberg
      • Bethlehem, Pennsylvania, 미국, 18015
        • Saint Luke's University Hospital-Bethlehem Campus
      • Bryn Mawr, Pennsylvania, 미국, 19010
        • Bryn Mawr Hospital
      • Chambersburg, Pennsylvania, 미국, 17201
        • Chambersburg Hospital
      • Chambersburg, Pennsylvania, 미국, 17201
        • WellSpan Medical Oncology and Hematology
      • Collegeville, Pennsylvania, 미국, 19426
        • Main Line Health Center-Collegeville
      • East Stroudsburg, Pennsylvania, 미국, 18301
        • Pocono Medical Center
      • Easton, Pennsylvania, 미국, 18045
        • Saint Luke's Hospital-Anderson Campus
      • Ephrata, Pennsylvania, 미국, 17522
        • Ephrata Cancer Center
      • Exton, Pennsylvania, 미국, 19341
        • Main Line Health Center-Exton
      • Gettysburg, Pennsylvania, 미국, 17325
        • Adams Cancer Center
      • Hanover, Pennsylvania, 미국, 17331
        • WellSpan Medical Oncology and Hematology
      • Hazleton, Pennsylvania, 미국, 18201
        • Lehigh Valley Hospital-Hazleton
      • Lebanon, Pennsylvania, 미국, 17042
        • Sechler Family Cancer Center
      • Media, Pennsylvania, 미국, 19063
        • Riddle Memorial Hospital
      • Newtown Square, Pennsylvania, 미국, 19073
        • Bryn Mawr Health Center
      • Paoli, Pennsylvania, 미국, 19301
        • Paoli Memorial Hospital
      • Philadelphia, Pennsylvania, 미국, 19104
        • University of Pennsylvania/Abramson Cancer Center
      • Philadelphia, Pennsylvania, 미국, 19104
        • Penn Presbyterian Medical Center
      • Pottstown, Pennsylvania, 미국, 19464
        • Pottstown Hospital
      • Quakertown, Pennsylvania, 미국, 18951
        • Saint Luke's Hospital-Quakertown Campus
      • Quakertown, Pennsylvania, 미국, 18951
        • Saint Luke's Hospital - Upper Bucks Campus
      • Sayre, Pennsylvania, 미국, 18840
        • Guthrie Medical Group PC-Robert Packer Hospital
      • Wynnewood, Pennsylvania, 미국, 19096
        • Lankenau Medical Center
      • York, Pennsylvania, 미국, 17403
        • WellSpan Health-York Cancer Center
      • York, Pennsylvania, 미국, 17403
        • WellSpan Health-York Hospital
      • York, Pennsylvania, 미국, 17403
        • Cancer Care Associates of York
    • South Carolina
      • Greenwood, South Carolina, 미국, 29646
        • Self Regional Healthcare
    • Texas
      • Bryan, Texas, 미국, 77802
        • Saint Joseph Regional Cancer Center
    • Virginia
      • Mechanicsville, Virginia, 미국, 23116
        • Bon Secours Memorial Regional Medical Center
      • Midlothian, Virginia, 미국, 23114
        • Bon Secours Saint Francis Medical Center
      • Midlothian, Virginia, 미국, 23113
        • Bon Secours Westchester Emergency Center
      • Norfolk, Virginia, 미국, 23505
        • Bon Secours DePaul Medical Center
      • Portsmouth, Virginia, 미국, 23707
        • Bon Secours Maryview Medical Center
      • Richmond, Virginia, 미국, 23235
        • VCU Massey Cancer Center at Stony Point
      • Richmond, Virginia, 미국, 23226
        • Bon Secours Saint Mary's Hospital
      • Richmond, Virginia, 미국, 23230
        • Bon Secours Cancer Institute at Reynolds Crossing
      • Richmond, Virginia, 미국, 23223
        • Bon Secours Richmond Community Hospital
      • Richmond, Virginia, 미국, 23298
        • VCU Massey Comprehensive Cancer Center
      • Suffolk, Virginia, 미국, 23435
        • Bon Secours Health Center at Harbour View
    • Washington
      • Aberdeen, Washington, 미국, 98520
        • Providence Regional Cancer System-Aberdeen
      • Bellevue, Washington, 미국, 98004
        • Overlake Medical Center
      • Bellingham, Washington, 미국, 98225
        • PeaceHealth Saint Joseph Medical Center
      • Burien, Washington, 미국, 98166
        • Saint Anne Hospital
      • Centralia, Washington, 미국, 98531
        • Providence Regional Cancer System-Centralia
      • Edmonds, Washington, 미국, 98026
        • Swedish Cancer Institute-Edmonds
      • Enumclaw, Washington, 미국, 98022
        • Saint Elizabeth Hospital
      • Everett, Washington, 미국, 98201
        • Providence Regional Cancer Partnership
      • Federal Way, Washington, 미국, 98003
        • Saint Francis Hospital
      • Issaquah, Washington, 미국, 98029
        • Swedish Cancer Institute-Issaquah
      • Kennewick, Washington, 미국, 99336
        • Kadlec Clinic Hematology and Oncology
      • Lacey, Washington, 미국, 98503
        • Providence Regional Cancer System-Lacey
      • Lakewood, Washington, 미국, 98499
        • Saint Clare Hospital
      • Longview, Washington, 미국, 98632
        • PeaceHealth Saint John Medical Center
      • Port Townsend, Washington, 미국, 98368
        • Jefferson Healthcare
      • Poulsbo, Washington, 미국, 98370
        • Harrison HealthPartners Hematology and Oncology-Poulsbo
      • Renton, Washington, 미국, 98055
        • Valley Medical Center
      • Seattle, Washington, 미국, 98107
        • Swedish Medical Center-Ballard Campus
      • Seattle, Washington, 미국, 98122
        • Swedish Medical Center-First Hill
      • Seattle, Washington, 미국, 98104
        • Pacific Gynecology Specialists
      • Seattle, Washington, 미국, 98122-5711
        • Swedish Medical Center-Cherry Hill
      • Sedro-Woolley, Washington, 미국, 98284
        • PeaceHealth United General Medical Center
      • Shelton, Washington, 미국, 98584
        • Providence Regional Cancer System-Shelton
      • Silverdale, Washington, 미국, 98383
        • Saint Joseph Medical Center Hematology and Oncology - Silverdale
      • Tacoma, Washington, 미국, 98405
        • Northwest Medical Specialties PLLC
      • Tacoma, Washington, 미국, 98405
        • Franciscan Research Center-Northwest Medical Plaza
      • Vancouver, Washington, 미국, 98664
        • PeaceHealth Southwest Medical Center
      • Walla Walla, Washington, 미국, 99362
        • Providence Saint Mary Regional Cancer Center
      • Yakima, Washington, 미국, 98902
        • North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
      • Yelm, Washington, 미국, 98597
        • Providence Regional Cancer System-Yelm
    • West Virginia
      • Huntington, West Virginia, 미국, 25701
        • Edwards Comprehensive Cancer Center
    • Wisconsin
      • Appleton, Wisconsin, 미국, 54911
        • ThedaCare Regional Cancer Center
      • Ashland, Wisconsin, 미국, 54806
        • Duluth Clinic Ashland
      • Ashland, Wisconsin, 미국, 54806
        • Northwest Wisconsin Cancer Center
      • Berlin, Wisconsin, 미국, 54923
        • ThedaCare Cancer Care - Berlin
      • Burlington, Wisconsin, 미국, 53105
        • Aurora Cancer Care-Southern Lakes VLCC
      • Chippewa Falls, Wisconsin, 미국, 54729
        • Marshfield Clinic-Chippewa Center
      • Cudahy, Wisconsin, 미국, 53110
        • Aurora Saint Luke's South Shore
      • Eau Claire, Wisconsin, 미국, 54701
        • Marshfield Medical Center-EC Cancer Center
      • Germantown, Wisconsin, 미국, 53022
        • Aurora Health Care Germantown Health Center
      • Grafton, Wisconsin, 미국, 53024
        • Aurora Cancer Care-Grafton
      • Green Bay, Wisconsin, 미국, 54311
        • Aurora BayCare Medical Center
      • Hayward, Wisconsin, 미국, 54843
        • Essentia Health-Hayward Clinic
      • Kenosha, Wisconsin, 미국, 53142
        • Aurora Cancer Care-Kenosha South
      • La Crosse, Wisconsin, 미국, 54601
        • Gundersen Lutheran Medical Center
      • Ladysmith, Wisconsin, 미국, 54848
        • Marshfield Medical Center - Ladysmith
      • Marinette, Wisconsin, 미국, 54143
        • Aurora Bay Area Medical Group-Marinette
      • Marshfield, Wisconsin, 미국, 54449
        • Marshfield Medical Center-Marshfield
      • Milwaukee, Wisconsin, 미국, 53209
        • Aurora Cancer Care-Milwaukee
      • Milwaukee, Wisconsin, 미국, 53215
        • Aurora Saint Luke's Medical Center
      • Milwaukee, Wisconsin, 미국, 53233
        • Aurora Sinai Medical Center
      • Minocqua, Wisconsin, 미국, 54548
        • Marshfield Medical Center - Minocqua
      • Mukwonago, Wisconsin, 미국, 53149
        • ProHealth D N Greenwald Center
      • New Richmond, Wisconsin, 미국, 54017
        • Cancer Center of Western Wisconsin
      • Oconomowoc, Wisconsin, 미국, 53066
        • ProHealth Oconomowoc Memorial Hospital
      • Oshkosh, Wisconsin, 미국, 54904
        • Vince Lombardi Cancer Clinic - Oshkosh
      • Racine, Wisconsin, 미국, 53406
        • Aurora Cancer Care-Racine
      • Rice Lake, Wisconsin, 미국, 54868
        • Marshfield Medical Center-Rice Lake
      • Sheboygan, Wisconsin, 미국, 53081
        • Vince Lombardi Cancer Clinic-Sheboygan
      • Spooner, Wisconsin, 미국, 54801
        • Essentia Health-Spooner Clinic
      • Stevens Point, Wisconsin, 미국, 54482
        • Marshfield Medical Center-River Region at Stevens Point
      • Summit, Wisconsin, 미국, 53066
        • Aurora Medical Center in Summit
      • Superior, Wisconsin, 미국, 54880
        • Essentia Health Saint Mary's Hospital - Superior
      • Two Rivers, Wisconsin, 미국, 54241
        • Vince Lombardi Cancer Clinic-Two Rivers
      • Waukesha, Wisconsin, 미국, 53188
        • UW Cancer Center at ProHealth Care
      • Waukesha, Wisconsin, 미국, 53188
        • ProHealth Waukesha Memorial Hospital
      • Wausau, Wisconsin, 미국, 54401
        • Marshfield Clinic-Wausau Center
      • Wauwatosa, Wisconsin, 미국, 53226
        • Aurora Cancer Care-Milwaukee West
      • Weston, Wisconsin, 미국, 54476
        • Marshfield Medical Center - Weston
      • Wisconsin Rapids, Wisconsin, 미국, 54494
        • Marshfield Clinic - Wisconsin Rapids Center
    • Wyoming
      • Cheyenne, Wyoming, 미국, 82001
        • Cheyenne Regional Medical Center-West
      • Cody, Wyoming, 미국, 82414
        • Billings Clinic-Cody
      • Sheridan, Wyoming, 미국, 82801
        • Welch Cancer Center

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • RANDOMIZATION (STEP 1): Patient must be >= 18 years of age

  • RANDOMIZATION (STEP 1): Patient must have pathologically confirmed non-squamous non-small cell lung carcinoma (NSCLC). Patients with NSCLC not otherwise specified (NOS) are eligible. Mixed tumors will be categorized by predominant cell type. If small cell elements are present, the patient is ineligible

  • RANDOMIZATION (STEP 1): Patient must have metastatic stage IVA or IVB disease (includes M1a, M1b, and M1c), according to the 8th edition of the lung cancer TNM classification system. Recurrent metastatic NSCLC ineligible for curative therapy (in the treating investigator's opinion) is also allowed

  • RANDOMIZATION (STEP 1): Patient's tumor must be known negative for EGFR tyrosine kinase inhibitor (TKI) sensitizing mutations (for example at a minimum, negative for EGFR Exon 19 deletions, EGFR exon 20 insertions, and Exon 21 L858R, L861Q mutations ) AND negative for ALK gene rearrangements (by fluorescence in situ hybridization [FISH], next generation sequencing [NGS], or immunohistochemistry [IHC]) by routine Clinical Laboratory Improvement Amendments (CLIA)- or Food and Drug Administration (FDA)-certified clinical testing methods. CLIA or FDA approved circulating tumor deoxyribonucleic acid (DNA) testing is acceptable as an alternative to tissue testing

  • RANDOMIZATION (STEP 1): Patient must have radiographic and/or clinical progression (per local investigator assessment) following one, but only one, line of platinum-based chemotherapy AND one, but only one, line of prior checkpoint inhibitor (anti-PD-1 or PD-L1) immunotherapy, either concurrently or sequentially in either order. A minimum of two doses of prior immunotherapy is required. Only one prior line of therapy is allowed if patients received chemotherapy and immunotherapy together (patients may not receive subsequent single agent chemotherapy), and greater than two prior lines of therapy are not allowed.

    • NOTE: Lines of therapy are defined by clinical or radiographic progression. For patients with recurrent metastatic NSCLC following treatment for stage 1-3 NSCLC, platinum-based chemotherapy received within 12 months of recurrence and/or immunotherapy received within 6 months of recurrence will meet the requirement for prior chemotherapy and/or immunotherapy but subsequent receipt of more immunotherapy and/or platinum-based chemotherapy is also allowed.
    • NOTE: Prior anti-VEGF antibody therapy (ie bevacizumab) is allowed. Prior ipilimumab, or investigational agents not excluded below, in combination with the required prior therapies above are allowed.
    • NOTE: Prior receipt of one or two lines of targeted therapy for ROS1, RET, MET, BRAF, ERBB2/HER2, or KRAS G12C positive NSCLC is allowed and will not count toward the line of therapy limit. However, progression is still required after chemotherapy and immunotherapy as above. Patients with ROS1, RET, MET positive NSCLC are strongly encouraged to get appropriate targeted therapy (such as crizotinib, entrectinib, lorlatinib, selpercatinib, pralsetinib, capmatinib, tepotinib, or another investigational, off-label, or approved agent directed against ROS1, RET, or MET positive NSCLC) prior to participation and will be stratified.
    • NOTE: No prior predominantly VEGFR directed TKI therapy (such as cabozantinib, lenvatinib, or sitravantinib) is allowed, except for the agents named above.
  • RANDOMIZATION (STEP 1): The investigator must document the intended chemotherapy regimen should their patient be randomized to Arm C (docetaxel and ramucirumab, OR single agent chemotherapy - docetaxel, gemcitabine, paclitaxel, nab-paclitaxel). The patient must not have received the selected chemotherapy agent previously for metastatic disease

  • RANDOMIZATION (STEP 1): Any prior chemotherapy (based on administration schedule) must have been completed in greater than or equal to the following times prior to randomization:

    • FDA approved targeted oral therapy must be completed >= 1 week prior
    • Chemotherapy and/or immunotherapy must be completed >= 2 weeks prior
    • Prior investigational agents must be completed >= 4 weeks prior.
  • RANDOMIZATION (STEP 1): Prior radiation therapy is allowed with a 2 week washout prior to randomization. Patient must not receive any systemic treatment with radionuclides within 6 weeks prior to randomization. Patient must have no clinically relevant ongoing complication from prior radiation therapy

  • RANDOMIZATION (STEP 1): Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen (in the opinion of the treating physician) are eligible for this trial

  • RANDOMIZATION (STEP 1): Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents (such as anthracycline or HER2-directed antibody therapy, but not prior checkpoint inhibitor therapy), must have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, patients must be class 2B or better

  • RANDOMIZATION (STEP 1): Patient must have Eastern Cooperative Oncology Group (ECOG) performance status 0-1

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must have met the eligibility criteria outlined above

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must have measurable disease as defined by RECIST v1.1. Measurements must be obtained within 4 weeks prior to randomization/registration

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must have recovered to equal to or less than grade 1 toxicities related to prior treatment, unless toxicities are clinically non significant and/or stable on supportive therapy (as determined by the treating physician)

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Absolute neutrophil count >= 1,500/mcL (obtained within 2 weeks prior to randomization)

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Platelets >= 100,000/mcL (obtained within 2 weeks prior to randomization)

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Hemoglobin >= 9 g/dL (obtained within 2 weeks prior to randomization)

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (for patients with Gilbert's disease total bilirubin must be =< 3 x ULN) (obtained within 2 weeks prior to randomization)

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Aspartate aminotransferase (AST)(serum glutamic oxaloacetic transaminase [SGOT]) and alanine aminotransferase (ALT)(serum glutamate pyruvate transaminase [SGPT]) =< 2.5 x ULN (obtained within 2 weeks prior to randomization)

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Creatinine =< 1.5 x ULN OR calculated (Cockcroft-Gault formula) or measured creatinine clearance >= 50 mL/min/1.73m^2 (normalized to body surface area [BSA]) for patients with creatinine levels greater than 1.5 times the institutional normal creatinine =< 1.5 X ULN or creatinine clearance >= 50ml/min/1.73m^2 (obtained within 2 weeks prior to randomization)

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not be pregnant or breast-feeding due to the unknown effects of cabozantinib and nivolumab on human development and for the potential risk for adverse events in nursing infants with the treatment regimens being used.

    • All patients of childbearing potential must have a blood test or urine study within 14 days prior to randomization/registration to rule out pregnancy.
    • A patient of childbearing potential is anyone, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has achieved menarche at some point, 2) has not undergone a hysterectomy or bilateral oophorectomy; or 3) has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months).
  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not expect to conceive or father children by using accepted and effective method(s) of contraception or by abstaining from sexual intercourse for the duration of their participation in the study and for 6 months after completion of treatment on the study

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have clinically significant gastrointestinal bleeding within 6 months prior to randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have pulmonary hemorrhage or hemoptysis of >= 0.5 teaspoon (2.5 mL) of red blood within 3 months prior to randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have active drug induced pneumonitis within 3 months prior to randomization. Prior immune mediated pneumonitis of grade 3 or 4 are not eligible regardless of time window

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have current radiographic evidence of tumor invading major blood vessel, evidence of tumor cavitation > 1 cm, evidence of tumor invading the gastrointestinal (GI) tract (esophagus, stomach, small or large bowel, rectum or anus), or evidence of endotracheal or mainstem endobronchial tumor

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have peptic ulcer disease, known malabsorption syndrome, bowel obstruction or gastric outlet obstruction within 3 months prior to randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have abdominal fistula, GI perforation, or intra-abdominal abscess within 6 months prior to randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have grade 3 or greater infection, or infection requiring intravenous systemic treatment within 14 days prior to randomization. Patients must be off antibiotics at the time of randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have serious non-healing wound/ulcer/bone fracture within 28 days prior to randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have history of organ transplant

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have concurrent symptomatic untreated hypothyroidism

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have history of major surgery within 3 months prior to randomization, minor surgery within 28 days prior to randomization, other minor procedures within 7 days prior to randomization, or clinically relevant ongoing complications from prior procedures

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have concurrent uncontrolled hypertension defined as sustained blood pressure (BP) > 160 mm Hg systolic, or > 100 mm Hg diastolic despite optimal antihypertensive treatment

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have unstable angina pectoris, clinically-significant cardiac arrhythmias, stroke (including transient ischemic attack [TIA]), or myocardial infarction within 6 months prior to randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have a diagnosis of deep vein thrombosis/pulmonary embolism (DVT/PE) within 6 months of randomization unless stable, asymptomatic, and treated with low-molecular-weight heparin (LMWH) or a permitted oral anticoagulant for at least 7 days before randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must not be receiving anticoagulants (i.e., warfarin, aspirin, clopidogrel) except:

    • Prophylactic use of low-dose aspirin (100 mg po daily or less) and/or low dose molecular weight heparin (LMWH) is permitted.
    • Therapeutic doses of low dose molecular weight heparin (LMWH) or specified direct factor Xa inhibitors rivaroxaban, edoxaban, or apixaban are allowed in patients without untreated brain metastases who are on a stable dose 7 days prior to study randomization, and without clinically significant hemorrhagic complications from the anticoagulation regimen or the tumor
  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must not receive strong CYP3A4 inducers (e.g., dexamethasone (> 1 mg daily dosing), phenytoin, carbamazepine, rifampin, rifabutin, rifapentine, phenobarbital, and St. John's Wort) within 7 days prior to randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must have corrected QT interval calculated by the Fridericia formula (QTcF) =< 500 msec within 28 days prior to Step 1 randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must be able to swallow tablets

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must not be on continuous systemic treatment with corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications within 7 days prior to randomization, with the following exceptions:

    • Inhaled or topical steroids and adrenal replacement doses =< 10 mg daily prednisone equivalents are permitted in the absence of active autoimmune disease.
    • Patients are permitted to use topical, ocular, intra-articular, intranasal, and inhalational corticosteroids (with minimal systemic absorption).
    • Physiologic replacement doses of systemic corticosteroids are permitted, if < 10 mg/day prednisone equivalents. A brief course of corticosteroids for prophylaxis (e.g., contrast dye allergy) or for treatment of non-autoimmune conditions (e.g., delayed-type hypersensitivity reaction caused by contact allergen) is permitted
  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients with brain metastases are eligible as follows:

    • Previously treated brain metastases must have been treated with radiation > 2 weeks prior to randomization or surgery > 3 months prior to randomization OR
    • Untreated (active) brain metastases are allowed if they are clinically asymptomatic, < 1 cm, non-hemorrhagic, the patient is not on systemic anticoagulation, and the investigator believes that central nervous system (CNS) specific treatment is unlikely to be required during the first 3 months of study treatment.
    • NOTE: Symptomatic leptomeningeal disease is NOT allowed
  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must not have known active autoimmune disease or known history of autoimmune disease for which recurrence may affect vital organ function or require immune suppressive treatment including systemic corticosteroids (e.g., immune-related neurologic disease, multiple sclerosis, autoimmune neuropathy, Guillain-Barre syndrome, etc.).

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients with known history of human immunodeficiency virus (HIV)-infection must be on effective anti-retroviral therapy with undetectable viral load within 6 months of randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients with known history of chronic hepatitis B virus (HBV) infection must have undetectable HBV viral at time of randomization (suppressive therapy is allowed, if indicated)

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients with a known history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load at time of randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must not have had any prior allergic reaction or hypersensitivity to study drug components or related drugs (multitargeted small molecule tyrosine kinase inhibitors or checkpoint inhibitor monoclonal antibodies)

  • STEP 2 (CROSSOVER ARM Z): Patient must have met all eligibility requirements for Step 1 at time of registration to Step 1 to be eligible for Step 2

  • STEP 2 (CROSSOVER ARM Z): Patient must have radiographic progressive disease per RECIST criteria after >= 2 cycles of therapy on Arm C. The scan showing progression must be completed within 6 weeks prior to Step 2 registration

  • STEP 2 (CROSSOVER ARM Z): Patient must not have intervening anticancer treatment or major surgical procedure(s) between Step 1 and Step 2, except palliative radiation which was completed >= 1 week prior to registration to Step 2

  • STEP 2 (CROSSOVER ARM Z): Patient may not have central nervous system progression, but patients with stable CNS disease are allowed

  • STEP 2 (CROSSOVER ARM Z): Patient must have an ECOG performance status 0-2

  • STEP 2 (CROSSOVER ARM Z): Patient must have recovered to equal to or less than grade 1 toxicities related to prior treatment, unless the adverse event(s) are clinically non significant and/or stable on supportive therapy (as determined by the treating physician)

  • STEP 2 (CROSSOVER ARM Z): Absolute neutrophil count >= 1,500/mcL (obtained within 2 weeks prior to registration to Step 2)

  • STEP 2 (CROSSOVER ARM Z): Platelets >= 100,000/mcL (obtained within 2 weeks prior to registration to Step 2)

  • STEP 2 (CROSSOVER ARM Z): Hemoglobin >= 9 g/dL (obtained within 2 weeks prior to registration to Step 2)

  • STEP 2 (CROSSOVER ARM Z): Total bilirubin =< 1.5 x institutional ULN (for patients with Gilbert's disease total bilirubin must be =< 3 x ULN) (obtained within 2 weeks prior to registration to Step 2)

  • STEP 2 (CROSSOVER ARM Z): AST(SGOT) and ALT(SGPT) =< 2.5 x ULN (obtained within 2 weeks prior to registration to Step 2)

  • STEP 2 (CROSSOVER ARM Z): Creatinine =< 1.5 x ULN OR calculated (Cockcroft-Gault formula) or measured creatinine clearance >= 50 mL/min/1.73m^2 (normalized to BSA) for patients with creatinine levels greater than 1.5 times the institutional normal creatinine =< 1.5 X ULN or creatinine clearance >= 50ml/min/1.73m^2 (obtained within 2 weeks prior to registration to Step 2)

  • STEP 2 (CROSSOVER ARM Z): Patient must have corrected QT interval calculated by the Fridericia formula (QTcF) =< 500 ms within 28 days prior to Step 2 registration

  • STEP 2 (CROSSOVER ARM Z): Patient must not have any intercurrent illness or disease complication that the investigator believes would limit the ability to safely tolerate the combination of cabozantinib and nivolumab

  • STEP 2 (CROSSOVER ARM Z): Patient must not be pregnant or breast-feeding due to the unknown effects of cabozantinib and nivolumab on human development and for the potential risk for adverse events in nursing infants with the treatment regimens being used.

    • All patients of childbearing potential must have a blood test or urine study within 14 days prior to registration to Step 2 to rule out pregnancy.
    • A patient of childbearing potential is anyone, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has achieved menarche at some point, 2) has not undergone a hysterectomy or bilateral oophorectomy; or 3) has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months).
  • STEP 2 (CROSSOVER ARM Z): Patients must not expect to conceive or father children by using accepted and effective method(s) of contraception or by abstaining from sexual intercourse for the duration of their participation in the study and for 6 months after completion of treatment on the study

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Step 1, Arm A (cabozantinib S-malate)

Patients in Step 1, Arm A receive cabozantinib S-malate PO QD. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit. Patients also undergo ECHO as clinically indicated, CT throughout the trial, and collection of blood on study.

Undergo CT

다른 이름들:
  • CT
  • 고양이
  • 고양이 스캔
  • 컴퓨터 축 단층 촬영
  • 전산화 단층 촬영
  • CT 스캔
  • 단층 촬영
  • 컴퓨터 축 단층 촬영(시술)
  • 컴퓨터 단층촬영(CT) 스캔
  • 진단 CAT 스캔
  • 진단 CAT 스캔 서비스 유형

Given PO

다른 이름들:
  • BMS-907351
  • 카보메틱스
  • 코메트릭
  • XL-184
  • XL184
  • 특대형 184

Undergo ECHO

다른 이름들:
  • 심초음파
  • EC

Undergo blood collection

다른 이름들:
  • 생물학적 샘플 수집
  • 생체 표본 수집
  • 표본 수집
  • 샘플 수집
실험적: Step 1, Arm B (cabozantinib S-malate, nivolumab)

Patients in Step 1, Arm B receive cabozantinib S-malate PO QD and nivolumab IV over 30 minutes on day 1. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit. Patients also undergo ECHO as clinically indicated, CT throughout the trial, and collection of blood on study.

Undergo CT

다른 이름들:
  • CT
  • 고양이
  • 고양이 스캔
  • 컴퓨터 축 단층 촬영
  • 전산화 단층 촬영
  • CT 스캔
  • 단층 촬영
  • 컴퓨터 축 단층 촬영(시술)
  • 컴퓨터 단층촬영(CT) 스캔
  • 진단 CAT 스캔
  • 진단 CAT 스캔 서비스 유형

Given PO

다른 이름들:
  • BMS-907351
  • 카보메틱스
  • 코메트릭
  • XL-184
  • XL184
  • 특대형 184

Undergo ECHO

다른 이름들:
  • 심초음파
  • EC

Given IV

다른 이름들:
  • BMS-936558
  • MDX-1106
  • 니보
  • ONO-4538
  • 옵디보
  • CMAB819
  • 니볼루맙 바이오시밀러 CMAB819
  • MDX 1106
  • MDX1106
  • BMS 936558
  • ABP 206
  • 니볼루맙 바이오시밀러 ABP 206
  • BCD-263
  • 니볼루맙 바이오시밀러 BCD-263
  • BMS936558
  • 오노 4538
  • ONO4538

Undergo blood collection

다른 이름들:
  • 생물학적 샘플 수집
  • 생체 표본 수집
  • 표본 수집
  • 샘플 수집
활성 비교기: Step 1, Arm C (standard chemotherapy)

Patients in Step 1, Arm C receive ramucirumab IV over 30-60 minutes and docetaxel IV over 1 hour on day 1, or docetaxel IV over 1 hour on days 1 and 8, or gemcitabine hydrochloride IV on days 1 and 8, or paclitaxel IV over 3 hours on day 1, or nab-paclitaxel IV over 30 minutes on days 1 and 8. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity and at the discretion of the treating physician. Patients also undergo ECHO as clinically indicated, CT throughout the trial, and collection of blood on study.

Given IV

다른 이름들:
  • 탁솔
  • 안자탁스
  • 아소탁스
  • 브리스타솔
  • 프락셀
  • 탁솔 콘첸트라트

Given IV

다른 이름들:
  • 탁소테레
  • 도세캐드
  • RP56976
  • 탁소테레 주사 농축액
  • RP 56976
  • RP-56976

Undergo CT

다른 이름들:
  • CT
  • 고양이
  • 고양이 스캔
  • 컴퓨터 축 단층 촬영
  • 전산화 단층 촬영
  • CT 스캔
  • 단층 촬영
  • 컴퓨터 축 단층 촬영(시술)
  • 컴퓨터 단층촬영(CT) 스캔
  • 진단 CAT 스캔
  • 진단 CAT 스캔 서비스 유형

Undergo ECHO

다른 이름들:
  • 심초음파
  • EC

Undergo blood collection

다른 이름들:
  • 생물학적 샘플 수집
  • 생체 표본 수집
  • 표본 수집
  • 샘플 수집

Given IV

다른 이름들:
  • ABI-007
  • 아브락산
  • 알부민 결합 파클리탁셀
  • ABI 007
  • 알부민 안정화 나노입자 파클리탁셀
  • 나노 입자 알부민 결합 파클리탁셀
  • 나노입자 파클리탁셀
  • 파클리탁셀 알부민
  • 파클리탁셀 알부민 안정화 나노입자 제제
  • 단백질 결합 파클리탁셀
  • ABI007
  • 파클리탁셀 단백질 결합
  • 파클리탁셀 나노입자 알부민 결합
  • 나베루클리프

Given PO

다른 이름들:
  • 젬자
  • dFdCyd
  • 디플루오로데옥시시티딘 염산염
  • 젬시타빈 HCI
  • LY-188011
  • LY188011
  • 리 188011

Given IV

다른 이름들:
  • LY3009806
  • LY 3009806
  • IMC-1121B
  • 사이람자
  • 항-VEGFR-2 완전 인간 단클론 항체 IMC-1121B
  • 단클론항체 HGS-ETR2
  • IMC 1121B
  • IMC1121B
  • LY-3009806
실험적: Step 2, Arm Z (cabozantinib S-malate, nivolumab)

Patients in Step 2, Arm Z receive cabozantinib S-malate PO QD and nivolumab IV over 30 minutes on day 1. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit. Patients also undergo ECHO as clinically indicated, CT throughout the trial, and collection of blood on study.

Undergo CT

다른 이름들:
  • CT
  • 고양이
  • 고양이 스캔
  • 컴퓨터 축 단층 촬영
  • 전산화 단층 촬영
  • CT 스캔
  • 단층 촬영
  • 컴퓨터 축 단층 촬영(시술)
  • 컴퓨터 단층촬영(CT) 스캔
  • 진단 CAT 스캔
  • 진단 CAT 스캔 서비스 유형

Given PO

다른 이름들:
  • BMS-907351
  • 카보메틱스
  • 코메트릭
  • XL-184
  • XL184
  • 특대형 184

Undergo ECHO

다른 이름들:
  • 심초음파
  • EC

Given IV

다른 이름들:
  • BMS-936558
  • MDX-1106
  • 니보
  • ONO-4538
  • 옵디보
  • CMAB819
  • 니볼루맙 바이오시밀러 CMAB819
  • MDX 1106
  • MDX1106
  • BMS 936558
  • ABP 206
  • 니볼루맙 바이오시밀러 ABP 206
  • BCD-263
  • 니볼루맙 바이오시밀러 BCD-263
  • BMS936558
  • 오노 4538
  • ONO4538

Undergo blood collection

다른 이름들:
  • 생물학적 샘플 수집
  • 생체 표본 수집
  • 표본 수집
  • 샘플 수집

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Progression-free survival (PFS) for patient population with non-squamous no-small cell lung cancer (NSCLC)
기간: After 58 events (From time of randomization to documented disease progression [site review of imaging] or death from any cause, whichever occurs first)

The final analysis of PFS will be performed when the full information of PFS is reached (i.e., 58 events for each of the two primary comparisons). The two primary comparisons of PFS will each use a logrank test stratified on the randomization stratification factors with a one-sided type I error rate of 10%. Estimates of PFS including medians and confidence intervals, will be calculated using the Kaplan-Meier method. Cox proportional hazards models, stratified, on the same factors, will be used to estimate the treatment hazard ratios. At the final analyses, in the event that both primary PFS comparisons of the combination of nivolumab with cabozantinib and cabozantinib alone versus the standard chemotherapy are statistically significant, PFS will be compared between the two experimental arms (combination of nivolumab with cabozantinib versus [vs.] cabozantinib alone), using a stratified log rank test with a one-sided type I error rate of 10%.

After 58 events (From time of randomization to documented disease progression [site review of imaging] or death from any cause, whichever occurs first)

2차 결과 측정

결과 측정
측정값 설명
기간
Overall survival (OS) for each arm
기간: From time of randomization to documented disease progression (site review of imaging) or death from any cause, whichever occurs first, assessed up to 3 years

The final analysis of OS will be performed when the full information of PFS is reached (i.e., 58 events for each of the two primary comparisons). OS will be tested in a hierarchical fashion if the primary comparison of PFS between treatment arms is statistically significant, using a log rank test stratified on the randomization stratification factors with a one-sided type I error rate of 10%. Estimates of OS, including medians and confidence intervals, will be calculated using the Kaplan-Meier method. Cox proportional hazards models, stratified, on the same factors, will be used to estimate the treatment hazard ratios. OS will be further tested in a hierarchical fashion if the comparison of PFS between the two experimental arms is statistically significant. Point estimates of all endpoints will be accompanied by the corresponding two-sided 80% confidence intervals. Subset analyses of PFS and OS by treatment arm will be estimated and compared within subsets.

From time of randomization to documented disease progression (site review of imaging) or death from any cause, whichever occurs first, assessed up to 3 years
Best objective response for each arm
기간: Every 6 weeks for the first year on study, and then every 12 weeks after year one

Will be evaluated via Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria. Response rates (complete response [CR] + partial response [PR]) and toxicity will be compared using Fisher's exact tests with a one-sided type I error rate of 10%; multivariable logistic regression modeling will be used to adjust for the effect of any covariates that are associated with these categorical outcomes. Modeling procedures will implement backward selection; variables significant at the 0.10 level in the univariate setting will be chosen for inclusion in an initial full model, and at each step the least significant variable will be removed from the model. Only those covariates with p < 0.05 will remain in any final models, unless there are factors identified by the study team as crucial to model interpretation. Point estimates of all endpoints will be accompanied by the corresponding two-sided 80% confidence intervals.

Every 6 weeks for the first year on study, and then every 12 weeks after year one
Toxicity profile of monotherapy with cabozantinib, and the combination of nivolumab and cabozantinib
기간: Up to 3 years after completion of study treatment

Will be determined using the Common Terminology Criteria for Adverse Events (CTCAE) criteria. Response rates (complete response [CR] + pathologic response [PR]) and toxicity will be compared using Fisher's exact tests with a one-sided type I error rate of 10%; multivariable logistic regression modeling will be used to adjust for the effect of any covariates that are associated with these categorical outcomes. Modeling procedures will implement backward selection; variables significant at the 0.10 level in the univariate setting will be chosen for inclusion in an initial full model, and at each step the least significant variable will be removed from the model. Only those covariates with p < 0.05 will remain in any final models, unless there are factors identified by the study team as crucial to model interpretation. Point estimates of all endpoints will be accompanied by the corresponding two-sided 80% confidence intervals.

Up to 3 years after completion of study treatment

기타 결과 측정

결과 측정
측정값 설명
기간
The RECIST1.1 response at each time point
기간: Every 6 weeks for the first year on study, and then every 12 weeks after year one

The measurement of each time point will be performed using the revised CHOI criteria will be only applied to arms A and B, which will include anti-angiogenic therapy. Both the RECIST1.1 and revised CHOI criteria will assess the overall best response as CR, partial PR, stable disease (SD), or progressive disease (PD). Their concordance will be assessed using the weighted Cohen's kappa coefficient (k) with quadratic weights. As a rule of thumb, the level of concordance between the two criteria will be considered poor (k <0), slight (k 0-0.20), fair (k 0.21-0.40), moderate (k 0.41-0.60), substantial (k 0.61-0.80), and almost perfect (k 0.81 - 1).

Every 6 weeks for the first year on study, and then every 12 weeks after year one
Agreement between central view and site review in terms of progression-free survival
기간: After the completion of study treatment

The progression status and the progression time will be assessed in agreement. The progression status is a binary measurement and the agreement will be assessed using the Cohen's kappa coefficient. For progression time, will assess the temporal agreement using the method developed by Zeng et al.

After the completion of study treatment
Correlative biomarker research
기간: After the completion of study treatment

Correlative biomarker research will be performed on tissue and blood specimens collected within this trial.

After the completion of study treatment

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Joel W Neal, ECOG-ACRIN Cancer Research Group

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2020년 7월 13일

기본 완료 (추정된)

2027년 3월 31일

연구 완료 (추정된)

2027년 3월 31일

연구 등록 날짜

최초 제출

2020년 3월 16일

QC 기준을 충족하는 최초 제출

2020년 3월 16일

처음 게시됨 (실제)

2020년 3월 17일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 12일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 11일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 계획 설명

NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page.

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

예

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다